Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations
Background: Increased expression of type I interferon (IFN)-regulated genes has been described in blood and tissue cells from patients with systemic lupus erythematosus (SLE) and other rheumatic disorders. Only isolated studies have examined the type I IFN gene expression in antiphosholipid syndrome...
Main Authors: | Eleni Palli, Evrydiki Kravvariti, Maria G. Tektonidou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00487/full |
Similar Items
-
Origin and pathogenesis of antiphospholipid antibodies
by: C.M. Celli, et al.
Published: (1998-06-01) -
ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01) -
β2GP1, Anti-β2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome
by: Yik C. Ho, et al.
Published: (2016-05-01) -
Antiphospholipid Antibody Profile in HIV/AIDS Patients
by: Inolyn Pandjaitan, et al.
Published: (2017-12-01) -
The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome
by: Anna Brusch
Published: (2016-06-01)